Liaoning Cheng Da Co Ltd (600739) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Liaoning Cheng Da Co Ltd stock ¥10.39, price ¥10.01, upside +3.8%, quality 50 out of 100. Rating: fairly valued. Calculated from audited financials with 11 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range ¥7.27 – ¥25.12 · fair‑value band ¥7.38 – ¥13.31 · the ¥10.01 price screens below the ¥10.39 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Liaoning Cheng Da Co in your weekly email
Every Wednesday you see whether Liaoning Cheng Da Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Liaoning Cheng Da Co., Ltd. engages in biopharmaceutical, financial investment, supply chain, energy development, and other businesses in China and internationally.
Show moreShow less
The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business.
It also offers financial service enterprises including securities, insurance, and funds; rabies vaccines for human use and inactivated Japanese encephalitis vaccines for human use; medical industry investment and medical enterprise management consulting; and computer software and hardware technology development, technology consulting, technology transfer, technical services, and selling of medical equipment and other businesses.
The company was founded in 1991 and is headquartered in Dalian, China.
Stock analysis
Liaoning Cheng Da Co Ltd (600739) currently trades at ¥10.01, while our model-based Fair Value estimate is ¥10.39, so the stock looks roughly fairly valued today (gap 3.7%).
Show more
Valuation
Bull case: the Economic Profit group reads highest at a median of ¥12.82 per share, and 4 of the 11 models we run sit above the ¥10.01 price.
Bear case: the Asset-Based group reads lowest at ¥2.90, and 7 of the 11 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥7.38 (bear) to ¥13.31 (bull), the price of ¥10.01 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Healthcare sector.
Mixed Growth: Spin-off in 2003: revenue and profit before it include the divested business. Growth is measured afresh from 2003.
Liaoning Cheng Da Co Ltd reported revenue of 9.9B CNY in FY2025 versus 18.4B CNY in FY2021, a compound −14.3%/yr. Reported net income was 737M CNY in FY2025, compounding −23.6%/yr from FY2021.
Key figures
Market cap 15.3B CNY (≈ $2.3B) Mid · P/E ratio 9.4 · P/S ratio 1.65 · EPS (TTM) ¥1.07 · Dividend yield 1.5% · Net margin 17.8% · Return on equity 3.6% · Return on assets (EBIT) 2.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).
What moves the price
The share trades about 23% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 33% fair-value upside, at 4%, 600739 screens richer than that median.
Fair Value models
Bear¥7.38Fair Value ¥10.39Bull¥13.31
Price ¥10.01 · Upside +3.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.7889 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Spin-off in 2003: revenue and profit before it include the divested business. Growth is measured afresh from 2003.
Revenue growth 1 year
−12.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.2%
Start year 2020 (pandemic). Over 10 years: +0.8% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
−31.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year−33.4%
Dividend (yield on the price)1.5%
Per share before 2003divided by the spin-off factor 1.0994
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−19.4% vs −1.8%, slowing
Profit margin 2018 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → −1%
2025 sits 221% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Compare Liaoning Cheng Da Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 77 stocks
Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score50 · Below median
Fair Value upside+3.8% · Above median
Profitability
Return on equity (12 months)3.6% · Below median
Return on assets2.3% · Below median
Net margin (12 months)27.6% · Top 25%
Operating margin (12 months)1.1% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−8.4% · Bottom 25%
Dividend yield (12 months)1.5% · Below median
Balance sheet
Debt / equity0.26× · Above median
Valuation Multiplesvs Medical Distribution median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Liaoning Cheng Da Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/600739
Frequently asked questions
Is Liaoning Cheng Da Co Ltd (600739) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of ¥10.39 versus a price of ¥10.01, about +4% upside (fairly valued).
What is the fair value of 600739?
Our model-based fair value for Liaoning Cheng Da Co Ltd is ¥10.39 (as of Nov 7, 2026), built from audited fundamentals. The current price: ¥10.01.
What is the quality score of 600739?
Liaoning Cheng Da Co Ltd has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Liaoning Cheng Da Co Ltd (600739)?
Our model-based price target is the fair value of ¥10.39 (as of Nov 7, 2026) from 11 valuation models. Cautious scenario ¥7.38, optimistic scenario ¥13.31. It is a calculation from audited fundamentals, not an analyst target.
What is the Liaoning Cheng Da Co Ltd stock forecast for 2026?
Our models put fair value at ¥10.39, about +4% upside versus a price of ¥10.01 (fairly valued). Cautious scenario ¥7.38, optimistic scenario ¥13.31. The calculation is refreshed regularly with new filings.
What is the revenue of Liaoning Cheng Da Co Ltd (600739)?
Liaoning Cheng Da Co Ltd reported trailing-twelve-month revenue of about 9.2B CNY (latest available figure, as of Nov 7, 2026).
Does Liaoning Cheng Da Co Ltd pay a dividend?
Liaoning Cheng Da Co Ltd currently shows a dividend yield of 1.50% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Liaoning Cheng Da Co Ltd (600739) and when is the ex-dividend date?
Liaoning Cheng Da Co Ltd pays a dividend of ¥0.15 per share a year, a dividend yield of 1.5%. The last ex-dividend date was Aug 13, 2026. The payout ratio is 14.0% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Liaoning Cheng Da Co Ltd (600739)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Liaoning Cheng Da Co Ltd it is ¥10.39 per share (as of Nov 7, 2026), against a price of ¥10.01. It is the blended result of 11 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Liaoning Cheng Da Co Ltd stock overvalued or undervalued in 2026?
As of Nov 7, 2026, 600739 trades below its calculated fair value: price ¥10.01, fair value ¥10.39, a gap of about +4% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 600739?
No. The price is what the market pays today (¥10.01); the fair value is what the company's own numbers justify (¥10.39). For Liaoning Cheng Da Co Ltd the two are ¥0.3800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Liaoning Cheng Da Co Ltd worth?
The market values Liaoning Cheng Da Co Ltd at about 15.3B CNY (market capitalisation, as of Nov 7, 2026). Per share that is ¥10.01; our models calculate a fair value of ¥10.39 per share.
What do the bullish and bearish scenarios say about 600739?
Our models span a range for Liaoning Cheng Da Co Ltd: cautious scenario ¥7.38, base ¥10.39, optimistic ¥13.31 per share (as of Nov 7, 2026, price ¥10.01). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 600739?
Liaoning Cheng Da Co Ltd trades at a price-to-earnings ratio of 9.4 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥10.39 is built from several models across several years. Other multiples: P/B 0.5, P/S 2.6.
How solid is the balance sheet of Liaoning Cheng Da Co Ltd (600739)?
Balance-sheet figures for Liaoning Cheng Da Co Ltd (as of Nov 7, 2026): return on equity 3.6%, debt of 0.26 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is 600739 from its 52-week high?
Liaoning Cheng Da Co Ltd trades at ¥10.01, about 23% below its 52-week high of ¥13.02 and 5% above the low of ¥9.55 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥10.39 is for.
Which stocks are comparable to Liaoning Cheng Da Co Ltd?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Liaoning Cheng Da Co Ltd stock attractive at the current price?
The data as of Nov 7, 2026: price ¥10.01, calculated fair value ¥10.39 (+4%), Quality Score 50/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 600739 calculated?
We run Liaoning Cheng Da Co Ltd through 11 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥10.39 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Liaoning Cheng Da Co Ltd currently trades 4% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Liaoning Cheng Da Co Ltd (600739)?
The closing price on Nov 6, 2026 was ¥10.01. Our model-based fair value is ¥10.39, about +4% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Liaoning Cheng Da Co Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (¥7.38 to ¥13.31) leaves room in how you read the outcome.
Where does the earnings growth of Liaoning Cheng Da Co Ltd (600739) come from?
Earnings per share at Liaoning Cheng Da Co Ltd grew −3.7 % a year from 2013 to 2024. Broken into its drivers: revenue per share +1.9 %, EBIT margin −6.4 %, tax rate −1.0 %, residual (interest, one-offs) +2.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Liaoning Cheng Da Co Ltd
How large is the market capitalisation of Liaoning Cheng Da Co Ltd (600739)?
The market capitalisation of Liaoning Cheng Da Co Ltd is 15.3B CNY (≈ $2.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Liaoning Cheng Da Co Ltd (600739)?
The price-to-sales ratio of Liaoning Cheng Da Co Ltd is 1.65 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Liaoning Cheng Da Co Ltd (600739)?
Earnings per share at Liaoning Cheng Da Co Ltd are ¥1.07 (price ÷ EPS = P/E 9.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Liaoning Cheng Da Co Ltd (600739)?
The dividend yield of Liaoning Cheng Da Co Ltd is 1.5% (payout 14.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Liaoning Cheng Da Co Ltd (600739)?
The net margin of Liaoning Cheng Da Co Ltd is 17.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Liaoning Cheng Da Co Ltd (600739)?
The return on equity (ROE) of Liaoning Cheng Da Co Ltd is 3.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Liaoning Cheng Da Co Ltd (600739)?
On an EBIT basis the return on assets of Liaoning Cheng Da Co Ltd is 2.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Liaoning Cheng Da Co Ltd (600739)?
The operating margin of Liaoning Cheng Da Co Ltd is 1.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Liaoning Cheng Da Co Ltd (600739)?
Revenue at Liaoning Cheng Da Co Ltd is growing −8.4% versus a year earlier (3y avg −12.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Liaoning Cheng Da Co Ltd (600739)?
Earnings per share at Liaoning Cheng Da Co Ltd are growing +189% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Liaoning Cheng Da Co Ltd (600739) generate?
The free cash flow of Liaoning Cheng Da Co Ltd is −3.2M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Liaoning Cheng Da Co Ltd (600739) carry?
The net debt of Liaoning Cheng Da Co Ltd is 4.4B CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Liaoning Cheng Da Co Ltd in the live analysis
One click puts Liaoning Cheng Da Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 7, 2026